Ethical Considerations in Genetic Engineering and Gene Therapy

In 2018, the world was stunned when Chinese scientist He Jiankui announced he had edited the genes of two human embryos – and brought them to term. Harvard researchers described the announcement as a turning point in the debate over heritable gene therapies – not because the science was impossible, but because it exposed just how far ahead biotechnology had raced past its ethical guardrails. Genetic engineering and gene therapy hold extraordinary promise: the potential to eliminate hereditary diseases, ease suffering, and extend healthy life. But they also force us to confront some of the most difficult moral questions of our time. Who has the right to alter human DNA? What happens to human dignity when life can be designed? And how do we weigh individual benefit against the risks to future generations who have no say in the matter?

What is genetic engineering and gene therapy?
The morality of human genetic manipulation
“Playing God” – a philosophical concern, not just a religious one
Genetic diversity and the slippery slope to eugenics
The ethics of cloning
The Kantian perspective: dignity, duty, and limits
Intrinsic value of human life
Balancing innovation with ethical responsibility

What is genetic engineering and gene therapy?

Genetic engineering refers to the direct modification of an organism’s DNA – altering, deleting, or inserting genetic sequences to change inherited traits. Gene therapy takes this a step further by targeting specific genes within a patient’s body to treat or potentially cure disease. With the rise of CRISPR technology, gene therapy has transitioned from a theoretical idea into a promising course of treatment currently being evaluated for diseases like cystic fibrosis, hemophilia, sickle cell anemia, and even certain cancers.

A critical distinction shapes much of the ethical debate: the difference between somatic editing and germline editing. Somatic editing modifies the cells of a living patient only – changes stay with that individual and are not passed on. Germline editing, by contrast, modifies eggs, sperm, or embryos, meaning any changes made are heritable and will be carried by all future descendants. While somatic gene editing affects only the patient being treated, germline editing affects all cells in an organism and is passed on to future generations – consequences that are difficult to predict. This irreversibility is at the heart of why germline intervention raises such profound ethical concern.

The morality of human genetic manipulation

The central moral question is deceptively simple: should humans have the right to alter the genetic code of other humans – especially those not yet born? On one side, proponents argue that if genetic modification can eliminate heritable diseases and prevent suffering, there may be a moral obligation to pursue it. On the other, critics point out that if genetic changes are passed to future generations, we could inadvertently alter the human gene pool in ways that are harmful or irreversible.

One persistent concern is the problem of informed consent. Future generations affected by germline edits cannot consent to those changes – and parents already making complicated decisions on behalf of future children does not fully resolve this ethical tension. The people most affected by a permanent genetic alteration simply do not exist yet at the time the decision is made. This is not a technicality – it is a foundational issue of autonomy and rights. Because of these consent concerns, the U.S. government does not allow federal funds to be used for germline gene therapy research in people.

“Playing God” – a philosophical concern, not just a religious one

The phrase “playing God” is often dismissed as a purely religious objection, but its philosophical weight is more significant than it first appears. The philosopher Hans Jonas, whose work shaped the bioethical tradition in the United States, described cloning and recombinant DNA technology as trespasses into a sacred realm – not as a theological claim, but as a secular argument that human dignity is grounded in organic processes of life itself.

The concern here is not that science must defer to religion. It is that certain interventions – particularly irreversible ones that affect people who cannot consent – risk crossing a line where human life is treated as raw material to be engineered rather than a reality to be respected. As Leon Kass, former chair of the U.S. President’s Council on Bioethics, framed it: the debate is really about whether we wish to “put human nature itself on the operating table, ready for alteration, enhancement, and wholesale redesign.” The worry is not progress itself, but the absence of ethical limits on what progress is permitted to do to human beings.

Genetic diversity and the slippery slope to eugenics

One of the most serious structural risks in genetic engineering is what it might do to human diversity over time. A frequently cited concern is that editing for disease and disability will lead to editing for enhancement – a slippery slope where one apparently reasonable decision leads to more extreme courses of action. Once it becomes acceptable to eliminate a genetic disease, what stops the same logic from being applied to select for intelligence, height, or temperament?

This trajectory leads directly toward eugenics – the idea of engineering a “better” human population by selecting for desired traits. Genetic treatment to eliminate certain diseases could stigmatize people living with similar conditions, and society as a whole might become less compassionate or suffer from a reduced diversity of bodies and experiences. The American Medical Association has been direct on this: genetic manipulation should be reserved for therapeutic purposes, and efforts to enhance “desirable” traits are contrary to the ethical tradition of medicine.

There is also the issue of access. The high cost of gene therapy raises the concern that it will only be available to the wealthy, potentially creating genetic classes defined by the quality of their engineered genome. If only the privileged can afford genetic enhancements, these technologies risk entrenching inequality not just socially and economically, but biologically.

The ethics of cloning

Human cloning sits at the extreme end of genetic intervention and raises its own distinct moral questions. Concerns about eugenics have surfaced in cloning debates, since the technology could be used to produce humans with selected traits, violating principles of human dignity, freedom, and equality. Beyond eugenics, cloning threatens something more fundamental: individuality. Every person has a right to a unique biological identity and an open future – to become who they are without that being predetermined by someone else’s design choices.

Human cloning would not only violate a person’s right to individuality, but would reduce diversity in the human gene pool – and it poses clear risks of using human beings as means to an end. The scenario of cloning individuals as organ donors, or to replicate a deceased loved one, reduces a human life to its biological utility. This is not a distant science fiction concern; the moral framework we build around these technologies now will determine whether such practices become thinkable in the future.

A distinction is drawn in the literature between reproductive cloning (creating a cloned human being) and therapeutic cloning (creating cloned embryos for medical research). Those who support therapeutic cloning argue there is a moral imperative to heal the sick and seek greater scientific knowledge, while opponents maintain it represents the manufacture and destruction of a human life. Neither side dismisses the other’s concern – and that tension reflects the genuine difficulty of drawing ethical lines in this domain.

The Kantian perspective: dignity, duty, and limits

Immanuel Kant’s moral philosophy offers a rigorous framework for evaluating genetic engineering. Central to his ethics is the categorical imperative – particularly the formulation that persons must always be treated as ends in themselves, never merely as means. From a philosophical standpoint, therapeutic human genome editing has been regarded as generally ethically acceptable when it upholds this principle – that is, when it is done for the genuine benefit of the individual being treated, with respect for their worth as a person.

Interestingly, Kantian ethics does not simply prohibit genetic engineering. Kant’s moral philosophy actually provides reasons that support genetic engineering – even germline and non-therapeutic forms – through his imperfect duties to seek one’s own perfection and the happiness of others. The key is the motivation and the means. Using genetic modification to reduce suffering and enhance a person’s capacity for rational moral agency may be consistent with Kantian duty. Using it to design people for others’ benefit – to serve social agendas, commercial interests, or parental preferences – would not be.

Genetic enhancements are not justifiable on Kantian grounds for purposes of fashion or personal whim unrelated to a person’s capacity to reason and make moral choices. The risks and benefits must be evaluated against concrete proposals, and the line between acceptable therapeutic use and unacceptable enhancement must be drawn with careful attention to what it means to respect a person’s rational autonomy. Forcing someone to undergo gene therapy – even for their apparent benefit – would violate Kantian ethics by overriding their will. Engineering traits in people who have not yet been born raises similar concerns about the autonomy of future persons.

Intrinsic value of human life

Underlying all of these debates is a deeper question about what human life is worth – not instrumentally, but intrinsically. Critics argue that genetic engineering risks reducing human life to mere biological machinery, critically undermining the philosophical foundations of human rights. When human DNA can be patented, when embryos can be screened and discarded, and when future people can be designed to specification, the question of whether we still regard human life as having unconditional value becomes urgent.

This is not an argument for halting science. The Nuffield Council on Bioethics has argued that influencing the characteristics of future generations could be ethically acceptable, provided interventions are consistent with the welfare of the person born and uphold principles of social justice and solidarity. What is being argued is that the ethical framework must come first – not as an afterthought applied once the technology already exists. The intrinsic dignity of human life is not a constraint on science; it is the reason science must be conducted with care.

Balancing innovation with ethical responsibility

In 2017, the US National Academies of Sciences, Engineering, and Medicine made formal recommendations for ethical human genome editing, emphasizing that governance should be undertaken by scientific bodies in collaboration with regulatory agencies. These efforts represent an acknowledgment that genetic technology cannot regulate itself – that independent ethical oversight is not optional but essential.

The challenge is to preserve the genuine benefits of genetic medicine – treating devastating inherited diseases, developing therapies for conditions once considered untreatable – without allowing those benefits to justify the erosion of human dignity. That balance requires ongoing philosophical scrutiny, not just scientific assessment. It requires asking not only “Can we?” but “Should we?” – and being willing to answer no when the honest answer is no.

What do you think? If genetic technologies can prevent suffering in future generations, does that create a moral obligation to use them – or does the inability of those future people to consent make such decisions ethically impermissible regardless of the outcome? And at what point does eliminating genetic disease end, and designing human beings begin?

How useful was this post?

Click on a star to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

References

PDF 📄

Table of Contents

What is genetic engineering and gene therapy? 🔗

The morality of human genetic manipulation 🔗

“Playing God” – a philosophical concern, not just a religious one 🔗

Genetic diversity and the slippery slope to eugenics 🔗

The ethics of cloning 🔗

The Kantian perspective: dignity, duty, and limits 🔗

Intrinsic value of human life 🔗

Balancing innovation with ethical responsibility 🔗